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t 6 7 33 Objective: A proof-of-concept study to assess the potential of a Deep Learning 8 34 (DL) based photoplethysmography PPG (‘DLPPG’) classification method to9 35 detect peripheral arterial disease (PAD) using toe PPG signals.
11 
12 36 Approach: PPG spectrogram images derived from our previously published 
13 
14 37 multi-site PPG datasets (214 participants; 31.3% legs with PAD by Ankle Brachial 
16 38 Pressure Index (ABPI)) were input into a pretrained 8-layer (5 Convolutional 
17 39 Layers + 3 Fully Connected Layers) AlexNet as tailored to the 2-class problem
18 
19 40 with transfer learning to fine tune the Convolutional Neural Network (CNN). k-fold 
21 41 random cross validation (CV) was performed [for k=5 and k=10], with each 
22 
23 
42 evaluated over k training / validation runs. Overall test sensitivity, specificity,
24 43 accuracy, and Cohen’s Kappa statistic with 95% confidence interval ranges were 
26 44 calculated and compared, as well as sensitivities in detecting mild-moderate
27 45 (0.5≤ABPI<0.9) and major (ABPI<0.5) levels of PAD.28 
29 46 Main results: Cross validation with either k = 5 or 10 folds gave similar diagnostic
31 47 performances. The overall test sensitivity was 86.6%, specificity 90.2% and 
32 
33 48 accuracy 88.9% (Kappa: 0.76 [0.70-0.82]) (at k=5). The sensitivity to mild-
34 49 moderate disease was 83.0% (75.5-88.9%) and to major disease was 100.0%
36 50 (90.5-100.0%).
37 
38 51 Significance: Substantial agreements have been demonstrated between the DL-
39 
52 based PPG classification technique and the ABPI PAD diagnostic reference. This 
41 53 novel automatic approach, requiring minimal pre-processing of the pulse
42 
43 54 waveforms before PPG trace classification, could offer significant benefits for the 
44 
55 diagnosis of PAD in a variety of clinical settings where low-cost, portable and 
46 














   
  
 





   
  
  








































t 6 7 63 Peripheral arterial disease (PAD) of the lower limbs is a common form of 8 9 64 widespread atherosclerosis and is associated with an increased risk of coronary 
11 
12 65 artery disease and stroke (Abdulhannan et al., 2012). PAD prevalence increases 
13 
14 66 with age, especially in smokers and diabetics. Its diagnosis can be made on 
16 67 clinical grounds, but other conditions such as musculoskeletal, spinal disease 
17 
18 68 and venous disease may also produce similar exercise induced symptoms. There 
19 
21 69 are a range of tests to assess patients for possible PAD and this includes the 
22 
23 70 widely used reference standard of an Ankle Brachial Pressure Index (ABPI) <0.9. 
24 
71 The operation of ABPI measurement, however, typically takes 10-30 minutes
26 
27 72 even by specialist operators, may be inaccurate with vessel calcification and can 28 
29 
73 cause discomfort and pain in some patients (Scott et al., 2019).
31 
32 
33 74 Ideally a vascular screening technology for PAD should be low-cost, quick, 
34 
75 reliable, repeatable, non-invasive, portable and simple to operate. One technique 
36 
37 76 that has this potential is the low-cost optical pulse wave technology:
38 
39 77 photoplethysmography (PPG). PPG signals are derived from the changes in the 
41 
42 78 blood volume in the microvascular bed of tissue, therefore can reflect on the 
43 
44 79 properties of cardiovascular system in time and frequency domains (Allen, 2007). 
46 
47 80 PPG signals can be measured at many different body sites (Perpetuini et al., 
48 
49 81 2019; Chan et al., 2019) although the toe site has been popular for developing 
51 82 methods to detect vascular disease. It is accepted that the peripheral PPG pulse 
52 
53 83 wave usually becomes damped, delayed and diminished with increasing severity 
54 
56 84 of PAD, which makes the PPG-based detection of PAD possible (Allen & Murray, 
57 






   
    
 
 
   
 
   
  
 
   
     
 
   
 
      
  
     
    
   
 
 
   
  




























t 6 7 87 investigated in subjects in different age groups and for PPG ‘AC’ as well as its8 9 88 lower frequency ‘DC’ components (Allen et al., 2008; Allen et al., 2005; Bentham
11 89 et al., 2018). The results indicate the potential value of using just bilateral great 
12 
13 90 toe PPG measurements for low-cost and simple-to-do PAD detection. It has been 
14 
16 91 suggested that the pulse wave from the great toe pad might be a better body site 
17 
18 92 than ankle in detecting PAD, especially in “challenging populations” as those 
19 
93 exhibiting arterial calcification (Herraiz-Adillo et al., 2020). 
21 
22 94 As a promising approach towards large-scale healthcare services, the analysis 23 
24 
95 of PPG signals based on deep learning (DL) has been recently applied to 
26 
27 96 cardiovascular field for the detection of heart rate (Reiss et al., 2019), 
28 
29 97 hypertension (Liang et al., 2018), arterial fibrillation (Cheng et al., 2020). DL can 
31 
32 98 accurately detect multiple PAD-related cardiovascular risks (e.g., hypertension, 
33 
34 99 diabetes, cerebral infarction) (Panwar et al., 2020). It has been suggested in two
36 
37 
100 recent studies that DL-based PPG analysis could be useful in the detection of 
38 
39 101 diseases of the arteries ( Lee et al., 2020; Panwar et al., 2020). A DL-based 
41 102 analysis of the second derivative of the finger PPG trace showed a high accuracy 
42 
43 103 in the prediction of the ABPI class for severity of arterial disease (accuracy
44 
104 98.34%, for six ABPI classes covering mild through to severe disease, arterial 46 
47 
48 105 hardening, and normal) (Lee et al., 2020), although there could have been 
49 
106 overtraining which compensated for known accuracy limitations with ABPI 
51 
52 107 reference for PAD. Since PAD symptoms can manifest themselves early in the 53 
54 
108 legs then it is considered appropriate to study the PPG measurements obtained 
56 
57 109 more directly from the lower limbs. However, as far as we know there is a clear 
58 





    
  
    
  
   
   
  







   
 
 
   
   
  
  




























t 6 112 potential of a DL-based method for automatically detecting the presence (or 7 8 9 113 absence) of PAD from the toe PPG measurements as well as its sensitivity to 
11 114 detecting higher and lower grade disease.
12 
13 11514 
16 116 2. Methods
17 
18 
19 117 2.1 Measurements
21 118 The physiological measurements are described in detail in (Allen et al., 2005; 
22 
23 119 Allen et al., 2008). In summary, they were performed in a warm temperature-
24 
26 120 controlled room (24 ± 1 oC), and at least 10 minutes were given for thermal 
27 
28 121 acclimatization and relaxation. Measurements were made by a single operator 
29 
122 (JA) with subjects in the supine position, firstly with the ABPI measurements for 
31 
32 
33 123 both legs as the ‘gold standard’ reference for the presence of PAD (i.e., <0.9, 
34 
124 using highest of the right and left ankle systolic blood pressures), and secondly 
36 
37 125 the bilateral PPG great toe pulse measurements from a multi-site PPG pulse 
38 
39 126 measurement concept prototype system. The PPG measurement system 
41 
42 127 simultaneously acquired bilateral toe pulses using electronically matched pairs of 
43 
44 128 right and left pulse amplifiers of bandwidth (0.15–20 Hz, single pole high pass 
46 129 filtering) with data captured to computer for subsequent pulse wave analysis for 
47 
48 
49 130 at least 2.5 minutes (Allen & Hedley, 2019). Subject age, gender and height were 












   
     












   
  
   
      
   
   
    
  
  




























t 6 7 135 DL-based PAD classifier and these sets are summarized in our 2005 pilot 8 9 136 evaluation paper (Allen 2002, Allen et al., 2005) and our 2008 prospective study 
11 137 paper (Allen et al., 2008). In summary, they comprised a mixture of older subjects, 
12 
13 138 with and without significant lower limb occlusive PAD. Subjects were excluded if 
14 
16 139 they had an obvious cardiac arrhythmia, lower limb amputation, vasculitis, 
17 
18 140 significant movement artefact (for example due to limb tremor), skin problems 
19 
141 (e.g., cuts or bruising at a measurement site or photosensitive skin) and 
21 
22 142 Raynaud’s phenomenon. We did not specifically exclude those with hypertension, 23 
24 
143 diabetes, hypercholesterolaemia, chronic renal failure or ischaemic heart disease 
26 
27 144 as these are all relevant to the atherosclerotic phenotype. All subjects gave their 
28 
29 145 written informed consent. More recent further ethical approval was also granted 
31 
32 146 for a further re-analysis of the anonymized sets of PPG waveforms (Newcastle 
33 
34 147 University Ethics Committee, 7840/2020). The combined 2 studies gave a total of 
36 
37 
148 218 potential subjects although a small number of these subjects (3) had elevated 
38 
39 149 ABPIs (>1.4 in either leg) which were excluded owing to the risk of false negative 
41 150 results observed when ABPI is used in calcified blood vessels. A further subject 
42 
43 151 was excluded as they were found to show a consistent cardiac arrhythmia on their
44 
152 pulse traces. In total therefore, PPG toe pulses from 214 subjects were available46 
47 
48 153 for subsequent DL classification and study, comprising 134 subjects having
49 
154 normal arteries in both legs and 80 subjects having significant vascular disease 
51 
52 
53 155 in at least one leg (i.e., 37.4% of the total by subject; 31.3% of legs having PAD)
54 








   
    
       
      
 
    
    
        
    
     
    
  
    
  
     
  
   
     
   
































4 159 2.3.1 Signal pre-processing
6 160 The raw PPG signals for right and left great toes over 2.5 minutes were pre-7 
8 
9 161 processed using detrending by removing their mean levels, and then normalizing




163 continuous wavelet transform (CWT, ‘amor’ i.e., Gabor wavelet MATLAB, 
16 164 MathWorks Inc., version 2020a) was applied and a spectrogram image produced 
17 
18 165 for each great toe measurement, i.e., for both right and left legs separately, and 
19 
166 covering the 2.5 minute period (log10 y-axis: 0.0312 to 8 Hz to capture the 
21 
22 167 dynamics of the PPG signal over time, Figure 1). The intensity for the colour bar 23 
24 
168 of each CWT spectrogram was auto scaled, the image then saved in *.png file 
26 
27 169 format. This gave 428 files (by ABPI reference standard: 292 / 136 legs without / 
28 
29 170 with PAD, in which 94 legs with mild-moderate disease and 40 legs with major 
31 
32 171 disease) for subsequent DL training and cross validation testing.
33 
34 172
36 173 2.3.2 Deep learning convolutional neural network and training
37 
38 
39 174 Convolutional Neural Network (CNN) is a class of DL networks that is designed 
41 175 to learn features from the input data using its multiple Convolutional Layers. The 
42 
43 176 DL analysis was performed using MATLAB Deep Learning Toolbox software (The 
44 
177 Mathworks Inc., Natick, Massachusetts, United States) on a standard computing 46 
47 
48 178 platform. AlexNet (http://alexlenail.me/NN-SVG/AlexNet.html) was used which is 
49 
179 a pre-trained CNN that has been pre-trained on a database named ImageNet 
51 
52 
53 180 consisting of more than 1.2 million images belonging to one thousand classes
54 
181 (Krizhevsky et al., 2012). AlexNet is well known (Krizhevsky et al., 2012; Lu et 
56 
57 182 al., 2019; Wang et al., 2019). Briefly, its structure has 8 layers: five Convolutional
58 
























































t 6 7 185 to the 2-class problem (Figure 2) (Wang et al., 2019). Transfer learning was 8 9 186 applied for fine tuning of specific layers of the CNN. Treating each leg separately, 
11 187 each great toe PPG spectrogram image was rescaled to the AlexNet CNN input 
12 
13 188 layer structure size of 227x227 pixels, with 3-colour channels of red, green and 
14 
16 189 blue. The 2 CNN outputs gave the classification outcome of ‘no PAD’ and ‘PAD’.
17 
18 190 With the absence of fixed rules for deep learning parameter selection in the 
19 
191 literature then initial experiments were carried out within the Matlab Deep
21 
22 192 Learning Toolbox development environment to set the key parameters for23 
24 
193 AlexNet-based PAD / PPG application. The learning rate and the momentum 
26 
27 194 term parameters were initially and briefly explored in the ranges of 0.00001 to 
28 
29 195 0.01 and 0.4 to 0.9, respectively, with learning considered to be demonstrated 
31 
32 196 when there was a trajectory towards an accept ble classification performance 
33 
34 197 (e.g., 75-100%) at each fold tested (using 30 epochs with mini-batch size 20),
36 
37 
198 i.e., without the algorithm getting stuck at the low starting performance level. The 
38 
39 199 choice of number of epochs depends on training and validation error. Keeping 
41 200 the number of epochs small can lead to underfitting while making this number 
42 
43 201 high can lead to overfitting of the model. In our study, the validation error 
44 
202 trajectory approached a minimum at 30 epochs and hence this number was46 
47 
48 203 selected. Subsequently, a learning rate of 0.001 and momentum term of 0.5 were 
49 
204 selected for the k-fold cross validation testing as these showed learning across 
51 
52 205 all folds and carried out with reasonable speed. To aid the learning and53 
54 
206 generalization then pixel shift and image augmentation were also incorporated 
56 






   
  
   
 
     
  
   
  
   
   
    
  
      
 
   
  
  



































t 6 210 As there is no standardization in the choice of k for k-fold random cross validation 7 8 9 211 we experimented with two different values (k=5 and k=10), with k training / 




213 (Dall’Olio et al., 2020; He et al., 2016). For each training run the image sets were
16 214 randomly split into a training set and a validation set, with transfer learning from
17 
18 215 the PPG spectrogram images. At each training run the confusion matrix was 
19 
216 updated, and on the completion of all runs the overall test sensitivity, specificity 
21 
22 217 and accuracy (with 95% confidence interval ranges) were calculated. The23 
24 
218 process was repeated for k set to 10 enabling a simple comparison of the 
26 




32 221 2.3.5 Statistical analysis and diagnostic perform nce assessments
33 
34 222 Clinical measurements were summarized using median and inter-quartile range 
36 223 [IQR, 25th percentile to 75th percentile], calculated using simple Microsoft Office 
37 
38 
39 224 Excel spreadsheet functions. Cross-tabulation of PAD status by ABPI and DL
41 225 classifier was performed from which associated diagnostic test accuracy (DTA) 
42 
43 226 measures of sensitivity, specificity, and diagnostic accuracy, were determined 
44 
227 alongside associated 95% confidence intervals overall, as well as per severity 46 
47 
48 228 classification. DTA statistical analyses were performed using SciStat.com online 
49 
229 statistical software © 2020 MedCalc Software Ltd. The sensitivities in detecting 
51 
52 230 overall disease (ABPI<0.9), mild-moderate disease (0.5≤ABP<0.9) and major 53 
54 




232 Cohen’s Kappa statistic and 95% CI ranges were also calculated for the 
59






   
  
  
   
    
        
   
  
   
   
   
 
       
   
      
 
    
 
  
     
  




























t 6 235 moderate agreement; between 0.61 and 0.8 represents substantial agreement; 7 8 9 236 and 0.81 and 1.00 represents almost perfect agreement.
11 237
12 
13 238 3. Results
14 
16 239 Toe PPG pulse spectrogram images from a total of 214 subjects (137 males, 77 
17 
18 240 females) were classified using deep learning. The median [IQR] age was 64 [52
19 
241 - 72] years, systolic blood pressure 142 [128 - 160] mmHg, and height 1.69 [1.60
21 




27 244 The overall diagnostic performances with AlexNet DL classification are shown in 
28 
29 245 Tables 1 and 2, with all comparisons having substantial agreement (by Cohen’s 
31 
32 246 Kappa statistic, i.e., for agreement beyond chance) with ABPI. The tables also 
33 
34 247 summarize the values (and 95% CI ranges) of sensitivity, specificity and accuracy 
36 
37 
248 for k=5 (and 10) over the k repeat training / validation runs. 
38 
39 249 For k=5 the overall test sensitivity was 86.6 (95% CI: 80.6-91.3) %, specificity 
41 250 90.2 (86.2-93.3) %, accuracy 88.9 (85.7-91.6) %, and Kappa 0.76 [0.70-0.82]).42 
43 
44 251 The test sensitivity was clearly higher overall for the legs with higher grade PAD, 




253 major disease, giving Cohen’s Kappa values of 0.72 (0.65-0.79) and 0.67 (0.56-
51 254 0.78), respectively.
52 
53 
54 255 For k=10 the results were similar to the k=5 results, with overall test sensitivity
56 256 82.4 (95% CI: 74.8-88.5) %, specificity 89.0 (84.8-92.3) % and accuracy 86.9
57 







     
  
  
    
  
    
  
   
   
     
  
  
   
   
 
  
    
 
   
 





























t 6 259 for mild-moderate disease vs 97.1 (84.7-99.9) % for major disease, giving 7 8 9 260 Cohen’s Kappa values of 0.64 (0.55-0.73) and 0.61 (0.50-0.73), respectively.
11 26112 
13 
14 262 4. Discussion
16 263 An innovative DL-based PPG Classifier (‘DLPPG’) approach using pre-trained 
17 
18 264 Convolutional Neural Network AlexNet with fine tuning by transfer learning to 19 
21 265 diagnose PAD from toe PPG measurements has been evaluated in this study, 
22 
23 266 with performance assessed in this proof-of-concept study to show substantial 
24 
26 
267 agreements overall with the ABPI vascular reference for PAD.
27 
28 268 Currently, PAD diagnostics depends on mainly on ABPI measurement as the 
29 
31 269 first-line test. In the 2016 American Heart Association (AHA) / American College 
32 
33 270 of Cardiology (ACC) Guideline on PAD, the technological advancement for 
34 




272 direction (Gerhard-Herman et al., 2017). The proposed DL-based analysis of the 
39 
273 toe PPG signal provides the possibility for quick assessment and follow-up over 
41 
42 274 time, and low-cost management of PAD. The novel DL-based approach 
43 
44 275 assessed in this study has advantages over previously reported approaches
46 276 (e.g., analysis involving fiducial waveform characteristics) (Karimian et al., 2017)47 
48 
49 277 in PPG pulse analysis, with some earlier methods (Allen 2000; Allen et al., 2005; 
51 278 Allen et al., 2008) being resource intensive in pre-processing as they required the 
52 
53 
54 279 manual checking by an expert operator on a beat by beat basis to mark and 
56 280 exclude noisy pulses, and noting that derived pulse timing features and 
57 











     
  
   
 
  
   
 
 
     
   
  
   
  
 































t 6 283 new approach based on deep learning required minimal data pre-processing and 7 8 9 284 had no denoising stage.
11 285 The manual extraction of physiological parameters from time-frequency spectra 12 
13 
14 286 is cumbersome, highly parametrised, and tailored to specific scenarios, whereas 
16 287 the DL-based PPG analysis is appropriate for the large-scale application on
17 
18 288 bespoke measurement devices (Wilkes et al. 2015; Reiss et al., 2019) as well as 19 
21 289 centralised cloud-based signal diagnostics. Ultimately, such pulse assessments 
22 
23 290 could improve the management of patients with PAD by giving accessible and 
24 
26 
291 timely feedback to the patient and their doctors to help them reduce their 
27 
292 associated risk factors for cardiovascular disease.28 
29 
31 293 The AHA/ACC Guideline also highlighted the need for the improvement of clinical 
32 
33 294 classification systems for PAD that incorporate symptoms, anatomic factors, and 
34 




296 optimize treatment approach (Gerhard-Herman et al., 2017). Our results showed
39 
297 substantial accuracy, sensitivity, and Cohen’s Kappa values for legs with mild-
41 
42 298 moderate PAD as well as for major PAD, although the detection sensitivity was 
43 
44 299 lower for lower grade disease. These classification performances appear similar 
46 300 to the results of our earlier studies based on specific characteristics of the PPG 47 
48 
49 301 toe pulse, e.g., using careful manual extraction of normalised shape, risetime and 
51 302 amplitude features (Allen et. al. 2005; Allen et. al. 2008) for overall accuracy and 
52 
53 
54 303 differences with PAD severity in the legs. Our new approach also includes 
56 304 information on the dynamics of the PPG, i.e., the ‘DC’ lower frequency 
57 









    
   






    
  
 
   
  
   

































t 6 307 example for diabetic patients with PAD where there is autonomic involvement7 8 9 308 and/or vascular calcification, and this should be further explored as an exciting 
11 309 way forward in vascular assessment.
12 
13 
14 310 Other research groups have explored the use of DL-based PPG analysis in 
16 311 vascular assessments, including Lee et al. (2020) who used a convolutional long
17 
18 312 short term memory model (C-LSTM: with 5 convolutional layers, 5 pooling layers19 
21 313 and one LSTM layer) to classify the second derivative of the finger PPG trace to 
22 
23 314 predict the ABPI class i.e., severity of arterial disease (data from MIMIC-III 
24 
26 
315 database, Johnson et al., 2006). Their results are impressive and in 
27 
28 316 approximately 1000 subjects attained an accuracy of greater than 98% (for six 
29 
317 ABPI classes covering mild through to severe disease, arterial hardening, and 
31 
32 318 normal). They did combine 2 DL models (CNN and LSTM) which could have 
33 
34 319 improved performance, compared to the results from our single DL model.
36 
37 320 However, there may be an element of over-fitting which somehow compensates 
38 
39 321 for the imperfect ABPI reference for PAD. Such results do show what can be 
41 322 possible with deep learning. It will be very interesting future step for us to look at 42 
43 
44 323 both finger and toe PPG traces in our multi-site PPG measurements to see if 
46 324 classification performance can be boosted significantly.
47 
48 
49 325 A well-known aspect of PPG measurements is that movement artefact, e.g. 
51 326 movement of the limb during ambulation or even just whilst a patient is resting 
52 
53 
54 327 but talking, and changes in body posture can sometimes render a trace unusable 
56 328 (Carek et al., 2020); Huthart et al., 2020) and so a next step could be to test the 
57 























   
  































t 6 7 331 included in AlexNet, could enhance the algorithm robustness to noise, which has 8 9 332 been proven in parallel studies on the DL-based analysis of electrocardiogram 
11 333 (Muhammed and Aravinth, 2019). The development and application of CNN and 
12 
13 334 other DL-based methods could be investigated so that reliable evaluation of PAD 
14 
16 335 can be made in poor quality signals (Waugh et al., 2018).
17 
18 
19 336 Limitations and further work: A limitation of our proof-of-concept study is that the 
21 337 distribution of non-PAD, mild-moderate PAD, and major PAD cases was
22 
23 338 unbalanced. A future study should consider assessing unselected patients from 
24 
26 
339 primary care rather than specialist vascular centres. Due to the limitations on 
27 
28 340 data, we also did not include other (patho-)physiological factors in the model, 
29 
341 such as symptoms, history of heart disease, renal disease, and diabetes, etc. In 
31 
32 342 future studies, we will recruit a new cohort of cases and controls and include a 
33 
34 343 comparison with other PAD measures including the Edinburgh Claudication 
36 
37 344 Questionnaire (ECQ), manual leg pulse palpation, toe systolic pressures, and/or 
38 
39 345 duplex vascular ultrasound imaging (Kyle et. al., 2020). Diabetic patients should 
41 346 also be studied further particularly the PPG ‘AC’ and ‘DC’ lower frequency 42 
43 
44 347 components for with and without PAD cases (Bentham et al., 2018). Other CNN 




349 if they can boost the efficiency and accuracy of the classifications, particularly in 
51 350 earlier milder cases of disease. Other pathophysiological parameters (e.g.,
52 
53 351 symptoms, anatomic factors, and patient-specific risk factors) can be added to 
54 
352 achieve more accurate classification of PAD cases. Finally, based on the Health 
56 












   
     
      
 






























t 6 355 cost-effective, and real-time system to improve healthcare services diagnosis, 7 8 9 356 management, and treatment of PAD. 
11 35712 
13 
14 358 5. Summary
16 359 We have demonstrated in this proof-of-concept study that, with only limited signal 
17 
18 360 pre-conditioning, our DL-based PPG method can be configured reliably to detect 19 
21 361 PAD (as diagnosed by ABPI) from simple toe PPG measurements in a hospital 
22 
23 362 vascular department setting. The sensitivity of the technique was higher for more 
24 
26 
363 severe disease (i.e., an ABPI<0.5). Further works are already in progress to help 
27 
28 364 improve the classification algorithm and its resilience to noise and measurement 
29 
365 artefacts. Ultimately, the trajectory for the project area will be to use explainable
31 
32 366 AI techniques to help understand the complex changes in PPG characteristics 
33 














































































7 signals from the great toe. Clear differences can be seen between these PAD and non-PAD examples, for example in pulse 
8 
9 harmonics, variability over time as well as the “AC” to “DC” lower frequency components.



































































































            
     
       
         
 
 
     
  
    
   












   
  






   
 
   
 





   
  



































7 Tables 1a and b 5-fold random cross validation with Confusion Matrix from 5
8 
training/validation runs and DTA performance for DLPPG vs ABPI-determined disease 9 
(Overall, Mild-Moderate, Major) on a leg basis. Cohen’s Kappa statistic for agreement






17 Diagnosis by ABPI DL-based PPG classification18 
19 No PAD PAD
21 
No PAD 266 2922 
23 
24 Mild-Moderate 23 112









37 Sensitivity (%) Specificity (%) Accuracy (%)
38 Kappa
39 










































           
     
       
          
 
 
     
  
    
   











   
  






   
 
   
 










































7 Tables 2a and b 10-fold random cross validation with Confusion Matrix from 10
8 training/validation runs and DTA performance for DLPPG vs ABPI-determined disease 9 
(Overall, Mild-Moderate, Major) on a leg basis. Cohen’s Kappa statistic for agreement








Diagnosis by ABPI DL-based PPG classification
19 No PAD PAD
21 
No PAD 258 3222 
23 
24 Mild-Moderate 22 75









36 Sensitivity (%) Specificity (%) Accuracy (%)
37 Kappa
38 
39 82.4 86.9 0.70
Overall
41 (74.8 – 88.5) (83.3 – 90.0) (0.63-0.77)
42 
43 Mild – 77.3 89.0 86.1 0.64
44 
46 Moderate (67.7 – 85.2) (84.8 - 92.3) (82.2 – 89.3) (0.55-0.73)
47 
97.1 89.8 0.6148 
Major49 
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